- Trials with a EudraCT protocol (6,408)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (33)
6,408 result(s) found for: Controlled clinical trial.
Displaying page 1 of 321.
| EudraCT Number: 2013-001616-30 | Sponsor Protocol Number: 000071 | Start Date*: 2013-09-17 | |||||||||||
| Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
| Full Title: A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing a... | |||||||||||||
| Medical condition: Infertility | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DK (Completed) ES (Completed) PL (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-000302-28 | Sponsor Protocol Number: EffICIENCY | Start Date*: 2020-05-04 |
| Sponsor Name:Mundipharma Pharmaceuticals S.L. | ||
| Full Title: Open randomized low interventional clinical trial to compare efficiency in symptom control between fluticasone propionate/formoterol k-haler at medium strength versus an high strength ICS/LABA for ... | ||
| Medical condition: Persistent moderate asthma uncontrolled | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-003812-23 | Sponsor Protocol Number: 107014 | Start Date*: 2006-12-21 |
| Sponsor Name:NV Organon | ||
| Full Title: Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa) | ||
| Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) AT (Completed) CZ (Completed) FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-005549-46 | Sponsor Protocol Number: TS-005-DK | Start Date*: 2009-01-21 | |||||||||||
| Sponsor Name:Hvidovre Hospital | |||||||||||||
| Full Title: A randomised, controlled prospective open parallel groups clinical trial for the evaluation of efficacy and safety of TachoSil® in women undergoing hysterectomy. A pilot study | |||||||||||||
| Medical condition: It is the intention with this clinical trial to evaluate wheter TachoSil may reduce the formation of postoperative haematomas on the vaginal cuff following hysterectomi. The presence of a postopera... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-004286-18 | Sponsor Protocol Number: HPA-PTSD-1 | Start Date*: 2008-08-05 |
| Sponsor Name:Central Institute of Mental Health | ||
| Full Title: Monocentric, Double-blind Placebo-Controlled, Randomized Cross-Sectional Clinical Trial of Hydrocortisone (10 and 30mg/d) in Outpatients with Posttraumatic-Stress- Disorder (PTSD) ... | ||
| Medical condition: Intrusions in patients with posttraumatic stress disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004029-87 | Sponsor Protocol Number: KCL/PCT-CT2004-1 | Start Date*: 2005-01-24 |
| Sponsor Name:Institute of Psychiatry | ||
| Full Title: Pillot randomised controlled trial of antidepressant switching for treatmetn-refractory depression in primary care | ||
| Medical condition: Depression | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004004-22 | Sponsor Protocol Number: 233928 | Start Date*: 2018-03-16 |
| Sponsor Name:University of Sussex | ||
| Full Title: A Multi-Centred, Open Label, Randomised Study Assessing the Cardiovascular Outcomes Following Treatment of White Coat Hypertension with Established Anti-Hypertensive Drugs versus Standard of Care i... | ||
| Medical condition: White Coat Hypertension | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-004291-21 | Sponsor Protocol Number: 33IC30_166855 | Start Date*: 2018-01-15 |
| Sponsor Name:Insel Gruppe AG - Inselspital Universitätsklinik für Kardiologie | ||
| Full Title: Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function – a multi-center, double-blind, randomized, placebo-controlled clinical trial – SERVE Trial | ||
| Medical condition: Adults with congenital heart disease (CHD) and a right ventricle (RV) in subaortic (systemic) position. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-000197-24 | Sponsor Protocol Number: renate koppensteiner | Start Date*: 2008-05-16 |
| Sponsor Name:MUW, Univ.Klinik f. Innere Medizin II, Abteilung f. Angiologie | ||
| Full Title: EFFECTS OF NICOTINIC ACID PLUS SIMVASTATIN VS. SIMVASTATIN ALONE ON CAROTID AND FEMORAL INTIMA-MEDIA THICKNESS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (NASCIT) – A RANDOMIZED CONTROLLED TRIAL | ||
| Medical condition: 200 consecutive patients with PAD and low serum HDL cholesterol levels (<45mg/dL in men, <55 mg/dL in women) will be enrolled in this single-center prospective randomized controlled open-label trial. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-004139-21 | Sponsor Protocol Number: CTU/2017/306 | Start Date*: 2020-04-22 | ||||||||||||||||
| Sponsor Name:University College London | ||||||||||||||||||
| Full Title: A randomised prospective open label pilot trial comparing mycophenolate mofetil (MMF) with no immunosuppression in adults with limited cutaneous systemic sclerosis MINIMISE-Pilot (Mycophenolate in ... | ||||||||||||||||||
| Medical condition: Limited cutaneous systemic sclerosis (lcSSc) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2006-003813-42 | Sponsor Protocol Number: 107015 | Start Date*: 2006-12-21 |
| Sponsor Name:NV Organon | ||
| Full Title: Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012 | ||
| Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) AT (Completed) CZ (Completed) FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-021186-70 | Sponsor Protocol Number: 10089DMCA-CS | Start Date*: 2010-10-01 |
| Sponsor Name:Belfast Health and Social Care Trust | ||
| Full Title: Keratinocyte growth factor in Acute lung injury to REduce pulmonary dysfunction – a randomised placebo controlled trial (KARE) | ||
| Medical condition: Acute Lung Injury | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-023121-38 | Sponsor Protocol Number: ICX-DEBRHY-2 | Start Date*: 2011-01-13 |
| Sponsor Name:Intercytex Ltd | ||
| Full Title: A prospective placebo controlled phase II study to evaluate the use of allogeneic fibroblasts for the treatment of skin erosions in recessive dystrophic epidermolysis bulllosa. | ||
| Medical condition: Recessive dystropic epidermolysis bullosa | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004262-34 | Sponsor Protocol Number: MM09-SIT-023 | Start Date*: 2020-04-28 | |||||||||||||||||||||
| Sponsor Name:Inmunotek, S.L. | |||||||||||||||||||||||
| Full Title: Randomized, placebo-controlled, prospective clinical trial of efficacy and safety for the treatment of rhinitis/rhinoconjunctivitis and asthma against a mixture of Dermatophagoides pteronyssinus an... | |||||||||||||||||||||||
| Medical condition: House dust mites allergy | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2016-004764-18 | Sponsor Protocol Number: 01-17 | Start Date*: 2017-07-24 |
| Sponsor Name:St Patrick’s Mental Health Services | ||
| Full Title: Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep Trial | ||
| Medical condition: Depression | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-000188-15 | Sponsor Protocol Number: AL1402ac | Start Date*: 2017-01-09 | |||||||||||||||||||||
| Sponsor Name:Allergopharma GmbH & Co. KG | |||||||||||||||||||||||
| Full Title: A multicenter randomized double-blind placebo-controlled clinical trial for evaluation of efficacy and safety of specific immunotherapy with an aluminium hydroxide-adsorbed allergoid preparation o... | |||||||||||||||||||||||
| Medical condition: allergic bronchial asthma and allergic rhinitis or rhinoconjunctivitis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: PL (Completed) LT (Completed) DE (Completed) ES (Completed) LV (Completed) AT (Completed) HR (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2013-001811-56 | Sponsor Protocol Number: Syst.Antibiotics&GBR | Start Date*: 2014-09-26 |
| Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde | ||
| Full Title: The effect of systemic antibiotics on clinical and patient-centered outcomes of implant therapy and simultaneous guided bone regeneration. A randomised controlled clinical trial. | ||
| Medical condition: | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-004374-27 | Sponsor Protocol Number: ProPATIent | Start Date*: 2006-10-12 |
| Sponsor Name:Philipps-University | ||
| Full Title: Prospective, randomized, doubleblind, placebo-controlled trial on changes in acetylcholine receptor antibody titres in autoimmune myasthenia gravis after influenza vaccination (ProPATIent) | ||
| Medical condition: Generalized Myasthenia gravis with positive antibodies against Acetylcholine-receptors (ICD10GM2006 G70.0) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-001570-42 | Sponsor Protocol Number: AirGOs-2 | Start Date*: 2018-05-07 |
| Sponsor Name:Helsinki University Hospital | ||
| Full Title: Aggravated airway inflammation: research on genomics and optimal treatments (AirGOs) | ||
| Medical condition: Acetylsalicylic acid (ASA-) exacerbated respiratory disease (AERD). | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-001521-19 | Sponsor Protocol Number: MS04062004 | Start Date*: 2004-09-01 |
| Sponsor Name:SEVAPHARMA a.s. | ||
| Full Title: An open clinical trial on teh efficacy of H-AL pollens (Grass mixture I) administered orally and sublingually in patients with indicated allergen immunotherapy (AIT) with Type I allergy mediated by... | ||
| Medical condition: Type I allergy to pollens mediated by IgE antibodies | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.